The cancer-associated Tn glycoform of MUC1, a neoantigen that is present in a variety of cancers, was found to be a good candidate, and anti-Tn-MUC1 CAR T cells demonstrated target-specific cytotoxicity in xenograft models of pancreatic cancer [210]. Here, MUC1 is linked to pancreatic neoplasm.